These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33418102)

  • 1. Preventing Colitis-Associated Colon Cancer With Antioxidants: A Systematic Review.
    Irrazabal T; Thakur BK; Croitoru K; Martin A
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1177-1197. PubMed ID: 33418102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A purified membrane protein from
    Wang L; Tang L; Feng Y; Zhao S; Han M; Zhang C; Yuan G; Zhu J; Cao S; Wu Q; Li L; Zhang Z
    Gut; 2020 Nov; 69(11):1988-1997. PubMed ID: 32169907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer.
    Irrazabal T; Thakur BK; Kang M; Malaise Y; Streutker C; Wong EOY; Copeland J; Gryfe R; Guttman DS; Navarre WW; Martin A
    Nat Commun; 2020 Apr; 11(1):1802. PubMed ID: 32286276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
    Short SP; Pilat JM; Barrett CW; Reddy VK; Haberman Y; Hendren JR; Marsh BJ; Keating CE; Motley AK; Hill KE; Zemper AE; Washington MK; Shi C; Chen X; Wilson KT; Hyams JS; Denson LA; Burk RF; Rosen MJ; Williams CS
    Gastroenterology; 2021 Apr; 160(5):1694-1708.e3. PubMed ID: 33388316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARI suppresses colitis-associated cancer development by maintaining MCP-1-mediated tumour-associated macrophage recruitment.
    Dai L; Liu Y; Yin Y; Li J; Dong Z; Chen N; Cheng L; Wang H; Fang C; Lin Y; Shi G; Zhang H; Fan P; Su X; Zhang S; Yang Y; Yang L; Huang W; Zhou Z; Yu D; Deng H
    J Cell Mol Med; 2020 Jan; 24(1):189-201. PubMed ID: 31578820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer.
    Pastille E; Faßnacht T; Adamczyk A; Ngo Thi Phuong N; Buer J; Westendorf AM
    Front Immunol; 2021; 12():669747. PubMed ID: 34025672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse Models of Colitis-Associated Colon Cancer.
    Manicassamy S; Prasad PD; Swafford D
    Methods Mol Biol; 2021; 2224():133-146. PubMed ID: 33606212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy.
    Sheng YH; Giri R; Davies J; Schreiber V; Alabbas S; Movva R; He Y; Wu A; Hooper J; McWhinney B; Oancea I; Kijanka G; Hasnain S; Lucke AJ; Fairlie DP; McGuckin MA; Florin TH; Begun J
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):33-53. PubMed ID: 32497793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
    Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies.
    Fantini MC; Guadagni I
    Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Glucocorticoid Receptor in Intestinal Epithelial Cells Alleviates Colitis and Associated Colorectal Cancer in Mice.
    Muzzi C; Watanabe N; Twomey E; Meers GK; Reichardt HM; Bohnenberger H; Reichardt SD
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1505-1518. PubMed ID: 33316454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis.
    Polosukhina D; Singh K; Asim M; Barry DP; Allaman MM; Hardbower DM; Piazuelo MB; Washington MK; Gobert AP; Wilson KT; Coburn LA
    Oncogene; 2021 Nov; 40(47):6540-6546. PubMed ID: 34625710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
    Yin Y; Wan J; Yu J; Wu K
    Inflamm Bowel Dis; 2023 Oct; 29(10):1648-1657. PubMed ID: 37202830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis.
    Hidalgo-García L; Ruiz-Malagon AJ; Huertas F; Rodríguez-Sojo MJ; Molina-Tijeras JA; Diez-Echave P; Becerra P; Mirón B; Morón R; Rodríguez-Nogales A; Gálvez J; Rodríguez-Cabezas ME; Anderson P
    Pharmacol Res; 2023 Sep; 195():106891. PubMed ID: 37586618
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Silveira DSC; Veronez LC; Lopes-Júnior LC; Anatriello E; Brunaldi MO; Pereira-da-Silva G
    World J Gastroenterol; 2020 Nov; 26(43):6782-6794. PubMed ID: 33268961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Gut Microbiota Combined with Upregulation of Intestinal Tight Junction Explains Anti-Inflammatory Effect of Corylin on Colitis-Associated Cancer in Mice.
    Chang ZY; Liu HM; Leu YL; Hsu CH; Lee TY
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
    Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
    Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing.
    Ahmad R; Kumar B; Thapa I; Tamang RL; Yadav SK; Washington MK; Talmon GA; Yu AS; Bastola DK; Dhawan P; Singh AB
    J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37815870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV inhibits AOM/DSS-induced colitis-associated tumorigenesis via activation of PPARγ signaling in mice.
    Liang J; Yang C; Li P; Zhang M; Xie X; Xie X; Chen Y; Wang Q; Zhou L; Luo X
    Phytomedicine; 2023 Dec; 121():155116. PubMed ID: 37776619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity.
    Lian Q; Yan S; Yin Q; Yan C; Zheng W; Gu W; Zhao X; Fan W; Li X; Ma L; Ling Z; Zhang Y; Liu J; Li J; Sun B
    Cell Mol Immunol; 2021 Feb; 18(2):350-362. PubMed ID: 32094504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.